These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1505404)

  • 41. In vitro blood compatibility evaluation of cuprophan and polyacrylonitrile membranes.
    Stefanovic V; Vlahovic P; Kostic S; Mitić-Zlatkovic M
    Nephron; 1998; 79(3):350-1. PubMed ID: 9678440
    [No Abstract]   [Full Text] [Related]  

  • 42. Leukopenia and complement activation induced by different dialysis membranes.
    Man NK; Tien NQ; Lesavre P; Funck-Brentano JL
    Contrib Nephrol; 1984; 37():142-8. PubMed ID: 6713867
    [No Abstract]   [Full Text] [Related]  

  • 43. L-fucose residues on cellulose-based dialysis membranes: quantification of membrane-associated L-fucose and analysis of specific lectin binding.
    Meissner C; Deppisch R; Hug F; Schulze M; Ritz E; Ludwig H; Hänsch G
    Glycoconj J; 1995 Oct; 12(5):632-8. PubMed ID: 8595253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes.
    Désormeaux A; Moreau ME; Lepage Y; Chanard J; Adam A
    Biomaterials; 2008 Mar; 29(9):1139-46. PubMed ID: 18078988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II receptor antagonist.
    Krieter DH; Canaud B
    Nephrol Dial Transplant; 2002 May; 17(5):943-4. PubMed ID: 11981096
    [No Abstract]   [Full Text] [Related]  

  • 46. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 47. Albumin treatment reduces in vitro platelet deposition to PMMA dialysis membrane.
    Remuzzi A; Boccardo P
    Int J Artif Organs; 1993 Mar; 16(3):128-31. PubMed ID: 8314634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.
    Ureña P; Herbelin A; Basile C; Zingraff J; Man NK; Drüeke T
    Contrib Nephrol; 1989; 74():71-8. PubMed ID: 2702149
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemodialysis membrane biocompatibility: the case of erythropoietin.
    Cheung AK; Hohnholt M; Leypoldt JK; DeSpain M
    Blood Purif; 1991; 9(3):153-63. PubMed ID: 1666293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II receptor antagonist.
    John B; Anijeet HK; Ahmad R
    Nephrol Dial Transplant; 2001 Sep; 16(9):1955-6. PubMed ID: 11522894
    [No Abstract]   [Full Text] [Related]  

  • 51. Thrombopoietic status of patients on haemodialysis.
    Bat T; Bat BE; El-Moghraby A; Patel S; Feng X; Dunbar CE; Sarac E
    Br J Haematol; 2016 Mar; 172(6):954-7. PubMed ID: 26887628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 53. Blood--dialyzer interactions: hemodynamic manifestations in an animal model.
    Walker JF; Lindsay RM; Sibbald WJ; Linton AL
    Artif Organs; 1984 Aug; 8(3):329-33. PubMed ID: 6477201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodialysis-triggered asthma.
    Aljama P; Brown P; Turner P; Ward MK; Kerr DN
    Br Med J; 1978 Jul; 2(6132):251-2. PubMed ID: 678892
    [No Abstract]   [Full Text] [Related]  

  • 55. Polymer structure and blood compatibility evaluation - application of an acrylonitrile copolymer.
    Courtney JM; Park GB; Fairweather IA
    Biomater Med Devices Artif Organs; 1976; 4(3-4):263-75. PubMed ID: 1021154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of dialyser membranes on extracellular and intracellular granulocyte and monocyte activation in ex vivo pyrogen-free conditions.
    Mahiout A; Courtney JM
    Biomaterials; 1994 Oct; 15(12):969-80. PubMed ID: 7530999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Membrane compatibility and clearance of hepatitis C virus in chronic dialysis patients.
    Adorati M; Pipan C; Botta G
    Nephron; 1999; 82(4):358. PubMed ID: 10450041
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents.
    Matata BM; Wark S; Sundaram S; Courtney JM; Gaylor JD; Bowry SK; Vienken J; Lowe GD
    Biomaterials; 1995 Nov; 16(17):1305-12. PubMed ID: 8573668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Membrane effect on platelet function during hemodialysis: a comparison of cuprophan and polycarbonate.
    Sreeharan N; Crow MJ; Salter MC; Donaldson DR; Rajah SM; Davison AM
    Artif Organs; 1982 Aug; 6(3):324-7. PubMed ID: 6217802
    [No Abstract]   [Full Text] [Related]  

  • 60. ACE inhibitors and AN69 membranes: absence of anaphylactoid reactions in haemodiafiltration process.
    Teruel JL; Pascual J; Serrano P; Ortuño J
    Nephrol Dial Transplant; 1992; 7(3):275. PubMed ID: 1315010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.